|
|
Omega-3,6,9
(Borage, Flaxseed & Fish Oil)
 
1200 mg / 90 capsules |
- borage oil 19% GLA
- flaxseed oil 53% ALA
- fish oil (marine lipids)
EPA 30%/ DHA 20%
- Palmitic acid (C16:0)...................
76.5 mg
- Stearic acid (C18:0)....................
49.8 mg
- Oleic acid (C18:1n-9).................
207.6 mg
- Linoleic acid (C18:2n-6)..............
217.3 mg
- Gamma linolenic acid
(C18:3n-6)... 86.2 mg
- Alpha linolenic acid
(C18:3n-3).... 231.9 mg
- Eicosapentaenoic acid
(C20:5n-3). 127.5 mg
- Docosahexaenoic acid
(C22:6n-3). 82.6 mg
|
|
|
| Ingredients: |
|
| Borage
Oil 19% GLA : |
400
mg |
| Flax
Seed Oil 53% ALA : |
400 mg |
| Fish
Oil 30% EPA / 20% DHA : |
400 mg
|
|
|
| Dosage
: 1 softgel /day |
|
Nutrisana's
Borage/Fish/Flax oil combination - a balanced EFA blend:
Nutrisana's balanced EFA blend
is formulated to provide a delicate balance of both omega-6 and omega-3
fatty acids to help meet your daily EFA requirements. There is a greater
focus on the omega-3 fatty acids, due to the relatively low levels
in the North American diet. Adequate levels of Omega-3 fatty acids
are lacking in today's typical diet because they are not abundant
in foods that are commonly consumed2. Although linoleic
acid is abundant in today's diet, the body may not be able to fully
utilize this fatty acid. For this reason, the conditionally essential
fatty acid GLA is included in this blend to help achieve adequate
omega-6 intake.
Borage Oil/Fish Oil/Flax Oil
Combination
Introduction:
Early in the century. there was
a deeply rooted belief that dietary fat was necessary for two primary
reasons: first, as a carrier of fat soluble nutrients, and second
as a concentrated form of energy. In 1929, however, Burr and Burr
announced that unsaturated fat was essential, and in 1930 they determined
that linoleic acid, and possible other fatty acids, were active1.
From this early research, the term "essential fatty acid" was both
established and accepted1. In the last seven decades, identification
of the therapeutic qualities of essential fatty acids has been an
active area of research in human nutrition. It is becoming increasingly
clear the critical role that essential fatty acids play in the maintenance
of good health.
The importance of
prostaglandin to health is well known (see text on primrose oil). There
are three types of prostaglandin: PG1, PG2 and PG3. These sometimes
play antagonistic roles in regulating sexual hormones and protecting
the cardiovascular system. Our typical diet, which is very rich in animal
fats, promotes production of PG2 in large quantities, thereby giving
rise to an imbalance among the three types of prostaglandin. Given this
imbalance, it may prove useful to supplement the diet with essential
fatty acids capable of promoting the synthesis of PG1 and PG3 by the
body.
For example, gamma-linolenic acid,
or GLA, which is present in borage oil, and linoleic acid (LA) and
alpha-linolenic acid (ALA), which come from flax, is a precursor of
type 1 prostaglandin synthesis (PG1). Eicosapentaenoic acid (EPA),
present in fish oil, gives rise to type 3 prostaglandin (PG3).
Nutrisana's OMEGA 3-6-9,
is the ultimate balanced combination of essential fatty acids. It will
provide you with enough nutritional supplements to protect you from
the effects of any imbalance that may arise among the three types of
prostaglandin. Each capsule contains no less than 76 mg GLA, 212 mg
ALA, 206 mg LA, 120 mg EPA and 80 mg DHA. (The mixture is immersed in
high quality oil). This is enough to ensure your daily maintenance dose
of essential fatty acids, and simultaneously protects your hormonal
system, your arteries and your heart.
Overview of Essential Fatty
Acids:
Essential Fatty Acids (EFAS) are
termed "essential" because the body cannot produce them, and must therefore
be obtained from the diet. EFAs are polyunsaturated fatty acids (PUFAs),
of which there are two classes - Omega-6 and Omega-3. The most important
PUFAs for human nutrition in each series are as follows:
| Omega-6: |
|
|
|
Linoleic Acid (LA) |
C18:2n6 |
|
Gamma Linolenic Acid (GLA) |
C1S:3n6 |
|
Dihomogamma Linolenic Acid
(OGLA) |
C20:3n6 |
|
Arachidonic Acid (AA) |
C20:4n6 |
| Omega-3: |
|
|
|
Alpha Linolenic Acid (ALA) |
C18:3n3 |
|
Eicosapentaenoic Acid (EPA) |
C20:5n3 |
|
Docosahexaenoic Acid (DHA) |
C22:6n3 |
Of these two classes.
only LA of the omega-6 series and ALA of the omega-3 series are considered
"essential". The remaining PUFAs can be considered "conditionally
essential" because, under normal conditions, they can be derived from
the metabolism of LA (if an omega-6 fatty acid) or ALA (if an omega-3
fatty acid) in the following pathways:
|
Metabolic
Pathway for Omega-6 Fatty Acids
|
| Linoleic
Acid (C18:2n-6) |
D-6-D |
| Gamma
Linolenic Acid (C18:3n-6) |
elongase |
| Dihomo-Gamma
Linolenic Acid (C20:3n-6) |
 |
 |
|
Cyclo-Oxygenase
|
Lypoxygenase
|
 |
 |
| PGE1 |
15OH-DGLA |
|
D-5-D
 |
| Arachidonic
Acid (C20:4n-6) |
 |
 |
| Cyclo-Oxygenase |
Lypoxygenase |
 |
 |
 |
 |
| PGE2 |
PGI2 |
TXA2 |
LTB4 |
|
|
 |
|
Function of Essential Fatty Acids:
Both omega-6 and omega-3 fatty acids
are stored in the cell membranes of tissues, and have two primary functions.
First they are structural components of cell membranes where they ensure
fluidity, stability, and act as gate-keepers in the cells. Their presence
in membranes also helps to ensure the integrity of the epidermal layer
of the skin and regulate moisture loss. Second, within the cell membrane,
they serve as substrates for the enzymes cyclooxygenase (COX) and lipoxygenase
(LO) which convert the omega-6 and omega-3 fatty acids into a number
of important, very active, short-lived, hormone-like compounds reterred
to as eicosanoids. The eicosanoids are twenty carbon compounds and include
prostaglandins (PG), thromboxanes CYX), and leukotrienes (LT). Ekosanoids
influence numerous metabolic activities including platelet aggregation
(blood cloning), inflammation, haemorrhage, vasoconstrialon and vasodilation,
as well as blood pressure and immune function. The omega-6 and omega-3
metabolic pathways are linked in that they both com pete for the same
desaturase and elongase enzymes However, these enzymes appear to give
preference to the omega-3 pathway over the omega-6. It is also important
to note that these two classes of PUFAs are metabolically and functionally
distinct because they exert opposing physiological functions3.
For this reason, it is highly important that balances of both omega-6
and omega-3 fatty acids are consumed.
Importance of an optimal
omegaE6:omega-3 fatty acid balance:
A number of sources indicate that
man evolved on a diet that consisted of a 1:1 ratio of omega-6 to omega-3
fatty acids3. Currently, the typical Western diet consists
of a 10:1 - 25:13 ratio, and maybe as high as 40:1. This
elevated ratio of omega-6 to omega-3 results in an imbalance between
these two classes. This high ratio is due in part to the development
of the modern "vegetable oil" industry, which has dramatically increased
the omega-6 intake in the form of linoleic acid; coupled with the discovery
of hydrogenation, which has dramatically decreased the alpha linolenic
acid component of vegetable oils. It is critical that this disturbance
in EFA balance is corrected via the consumption of appropriate amounts
of omega-6 and omega-3 fatty acids. In addition. due to the opposing
effects of the omega-6 and omega-3 families, an optimal balance is important
to achieve both homeostasis and normal development3. A ratio
of 4:1 of omega-6 to omega-3 has been recommended as an "optimum functional
ratio"2.
Impairment of Delta 6 Desaturase
(D6D) enzyme: In addition to the above mentioned imbalance, another
concern is that of inefficient D6D enzyme activity. In humans D6D is
the initial and rate limiting enzyme in both the omega-6 and omega-3
metabolic pathways (see figure 1 and figure 2). Although adequate
intakes of both LA and ALA may occur, the body may be unable to utilize
these fatty acids due to this impairment. D6D activity may be impaired
genetically, or by factors such as:
| High
dietary intake of Linoleic Acid |
Alcohol
consumption |
| Aging |
High
dietary trans-fatty acid intake |
| High
dietary cholesterol and tatry' acid intake |
Disease
conditions (ie. diabetes) |
| Low
levels of enzyme co-factors |
|
Due to the possible impairment of
the D6D enzyme, it is necessary that an adequate amount of the "conditionally
essential" omega-6 and omega-3 fatty acids, that bypass this limiting
D6D enzyme, are consumed4. Specifically, GLA, EPA and DHA
should be consumed in addition to the "essential fatty acids" LA and
ALA.
Nutrisana's Borage/Fish/Flax
oil combination - a balanced EFA blend:
Nutrisana's balanced EFA blend is
formulated to provide a delicate balance of both omega-6 and omega-3
fatty acids to help meet your daily EFA requirements. There is a greater
focus on the omega-3 fatty acids, due to the relatively low levels in
the North American diet. Adequate levels of Omega-3 fatty acids are
lacking in today's typical diet because they are not abundant in foods
that are commonly consumed2. Although linoleic acid is abundant
in today's diet, the body may not be able to fully utilize this fatty
acid. For this reason, the conditionally essential fatty acid GLA is
included in this blend to help achieve adequate omega-6 intake.
Borage oil - is the richest
plant source of the important omega-6 fatty acid GLA. GLA bypasses the
D6D enzyme to help achieve adequate omega-6 intake. GLA has been the
center of many areas of research, showing positive effects in areas
such as cardiovascular disease (high blood pressure, high cholesterol),
diabetes, immune system, rheumatoid arthritis, cancer, and skin function
(atopic eczema and psoriasis).
Fish oil - is a rich source
of both EPA and DMA. The positive effects of EPA and DHA have been documented
in areas such as high blood cholesterol, high blood pressure, cardiac
arrhythmia, pregnancy and infant brain development, and cancer.
Flax oil - is the richest
plant source of the omega-3 fatty acid ALA. The positive effects of
ALA have been well documented in areas such as high blood cholesterol,
high blood pressure, immune function, and cancer.
References:
1. Holtman, R.T., (1988). George
O. Burr and the Discovery of Essential Fatty Acids.
J Nutr. 118:535-540.
2. Holman, R.T., (1998). The Slow
Discovery of the Importance of w3 Essential Fatty Acids in Human Health.
J. Nutr. 128:427S-433S.
3. Sirnopoulos. A.P., (1991).
Omega-3 fatty acids in health and disease and in growth and development.
Am J Clin Nutr. 54:438-63.
4. Spielmann, D. et. al. (1988).
Alternative Lipids to usual n6 PUFAS: Gamma Linolenic Acid, Alpha
tinolenic Acid, Stearidonic Acid, EPA, Etc. Journal of Parenteral
and Enteral Nutrition.
Vol.12(6) pp 111S - 123S.
All material
and information presented by Nutrisana.com is intended to be used for
educational purposes only. The statements made about products have not
been evaluated by the Food and Drug Administration (U.S.). They are
not intended to diagnose, treat, cure or prevent any condition or disease.
Please consult with your own physician or health care practitioner regarding
the suggestions and recommendations made at Nutrisana.com.
Copyright
© 1998-2000 Nutrisana International inc., all rights reserve
|